News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
193,336 Results
Type
Article (8681)
Company Profile (86)
Press Release (184563)
Multimedia
Podcasts (4)
Webinars (7)
Section
Business (59805)
Career Advice (172)
Deals (9810)
Drug Delivery (11)
Drug Development (24974)
Employer Resources (15)
FDA (3417)
Job Trends (3487)
News (97827)
Policy (6853)
Tag
Academia (794)
Academic (1)
Accelerated approval (1)
Adcomms (1)
Allergies (22)
Alliances (20911)
ALS (41)
Alzheimer's disease (559)
Antibody-drug conjugate (ADC) (87)
Approvals (3515)
Artificial intelligence (224)
Autoimmune disease (37)
Automation (11)
Bankruptcy (46)
Best Places to Work (2927)
BIOSECURE Act (5)
Biosimilars (53)
Biotechnology (67)
Bladder cancer (35)
Brain cancer (13)
Breast cancer (152)
Cancer (1312)
Cardiovascular disease (75)
Career advice (162)
Career pathing (9)
CAR-T (59)
Cell therapy (162)
Cervical cancer (4)
Clinical research (21045)
Collaboration (705)
Company closure (2)
Compensation (156)
Complete response letters (8)
COVID-19 (495)
CRISPR (31)
C-suite (221)
Cystic fibrosis (40)
Data (1604)
Decentralized trials (1)
Denatured (3)
Depression (20)
Diabetes (107)
Diagnostics (1418)
Digital health (7)
Diversity (3)
Diversity, equity & inclusion (4)
Drug discovery (148)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (51)
Earnings (20278)
Editorial (5)
Employer branding (1)
Employer resources (13)
Events (27772)
Executive appointments (303)
FDA (4070)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (433)
Gene editing (45)
Generative AI (20)
Gene therapy (127)
GLP-1 (248)
Government (613)
Grass and pollen (1)
Guidances (103)
Healthcare (3971)
HIV (10)
Huntington's disease (16)
IgA nephropathy (21)
Immunology and inflammation (52)
Immuno-oncology (3)
Indications (13)
Infectious disease (540)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (15)
Intellectual property (55)
Interviews (18)
IPO (4274)
IRA (5)
Job creations (742)
Job search strategy (146)
Kidney cancer (3)
Labor market (13)
Layoffs (82)
Leadership (5)
Legal (1517)
Liver cancer (26)
Longevity (5)
Lung cancer (206)
Lymphoma (91)
Machine learning (24)
Management (7)
Manufacturing (170)
MASH (24)
Medical device (1964)
Medtech (1967)
Mergers & acquisitions (5818)
Metabolic disorders (241)
Multiple sclerosis (24)
NASH (1)
Neurodegenerative disease (67)
Neuropsychiatric disorders (3)
Neuroscience (874)
NextGen: Class of 2025 (1157)
Non-profit (991)
Now hiring (11)
Obesity (104)
Opinion (66)
Ovarian cancer (50)
Pain (31)
Pancreatic cancer (46)
Parkinson's disease (90)
Partnered (10)
Patents (102)
Patient recruitment (89)
Peanut (6)
People (17300)
Pharmaceutical (17)
Pharmacy benefit managers (2)
Phase I (7120)
Phase II (8914)
Phase III (6740)
Pipeline (940)
Policy (26)
Postmarket research (566)
Preclinical (3311)
Press Release (39)
Prostate cancer (49)
Psychedelics (3)
Radiopharmaceuticals (92)
Rare diseases (164)
Real estate (1592)
Recruiting (4)
Regulatory (5566)
Reports (11)
Research institute (969)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (4)
RSV (14)
Schizophrenia (44)
Series A (82)
Series B (57)
Service/supplier (3)
Sickle cell disease (15)
Special edition (2)
Spinal muscular atrophy (76)
Sponsored (10)
Startups (1379)
Stomach cancer (1)
Supply chain (22)
Tariffs (8)
The Weekly (1)
Vaccines (145)
Venture capital (20)
Weight loss (40)
Women's health (8)
Worklife (3)
Date
Today (74)
Last 7 days (218)
Last 30 days (857)
Last 365 days (9040)
2025 (7518)
2024 (10609)
2023 (12486)
2022 (17446)
2021 (17453)
2020 (15376)
2019 (11524)
2018 (8753)
2017 (9677)
2016 (8828)
2015 (10405)
2014 (7585)
2013 (6233)
2012 (6839)
2011 (7192)
2010 (6644)
Location
Africa (200)
Alabama (18)
Alaska (3)
Arizona (27)
Arkansas (2)
Asia (27046)
Australia (3459)
California (2647)
Canada (812)
China (543)
Colorado (70)
Connecticut (159)
Delaware (161)
Europe (30813)
Florida (233)
Georgia (41)
Idaho (6)
Illinois (130)
India (34)
Indiana (229)
Iowa (4)
Japan (225)
Kansas (18)
Kentucky (2)
Louisiana (5)
Maine (11)
Maryland (422)
Massachusetts (2303)
Michigan (19)
Minnesota (94)
Missouri (55)
Montana (11)
Nebraska (3)
Nevada (10)
New Hampshire (7)
New Jersey (749)
New Mexico (12)
New York (726)
North Carolina (243)
North Dakota (3)
Northern California (1364)
Ohio (47)
Oklahoma (7)
Oregon (6)
Pennsylvania (359)
Puerto Rico (3)
Rhode Island (13)
South America (235)
South Carolina (4)
Southern California (947)
Tennessee (29)
Texas (299)
United States (9265)
Utah (59)
Virginia (87)
Washington D.C. (12)
Washington State (191)
Wisconsin (30)
Wyoming (1)
193,336 Results for "horizon discovery ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
LPOXY Initiates $28M Series A Financing with 5 Horizons Ventures to Fund STOP-Cdiff Pivotal Trial
September 3, 2025
·
3 min read
Press Releases
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
October 28, 2025
·
3 min read
Press Releases
Quantum BioPharma Ltd. Announces Corporate Updates
October 30, 2025
·
11 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
October 14, 2025
·
1 min read
Press Releases
Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
October 27, 2025
·
5 min read
Press Releases
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025
October 14, 2025
·
10 min read
Press Releases
Rapafusyn Pharmaceuticals Closes Over-Subscribed $44 Million Series A Financing to Advance Its Non-Degrading Molecular Glue Drug Discovery Platform
BioTrack Capital and Yonjin Capital join Series A round alongside other investors including 3E Bioventures Capital, Proxima Ventures Ltd., and Lapam Capital Upsized and over-subscribed Series A total funding of $44 million secured Rapafusyn’s RapaGlue™ platform rapidly discovers non-degrading molecular glues, a validated and highly sought-after modality to address challenging disease targets
September 4, 2025
·
1 min read
Press Releases
Nielsen BioSciences Announces Expanded CANDIN License Agreement with Maruho Co. Ltd.
October 24, 2025
·
3 min read
Huntington’s disease
4 Huntington’s Therapies Chasing UniQure
Last month, “historic positive results” from uniQure’s gene therapy snapped the Huntington’s community out of years of failure. As the biotech prepares to submit for FDA approval,
BioSpace
looks at four more candidates on the near horizon.
October 27, 2025
·
6 min read
·
Heather McKenzie
Press Releases
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 2, 2025
·
1 min read
1 of 19,334
Next
